Literature DB >> 30990778

Extended Extracorporeal Shockwave Therapy for Chronic Diabetic Foot Ulcers: A Case Series.

Wen-Yi Chou1, Ching-Jen Wang1, Jai-Hong Cheng2, Jen-Hong Chen1, Chien-Chang Chen2, Yur-Ren Kuo3.   

Abstract

INTRODUCTION: It is hypothesized that cumulative extended application of extracorporeal shockwave therapy (ESWT) can be beneficial to sustain the effect of ESWT and improve the long-term outcome in chronic diabetic foot ulcers (DFUs).
OBJECTIVE: The purpose of this study is to investigate the effectiveness of multiple extended booster ESWT to maintain the effects of ESWT on the outcomes of chronic DFUs.
MATERIALS AND METHODS: Four patients with a DFU were treated with ESWT, including 1 patient with 12 treatments and 3 patients with 6 treatments. Evaluations included clinical assessment, blood flow perfusion, and biopsy of the ulcers.
RESULTS: At 48 weeks, the results showed completely healed ulcers in 2 patients and improved ulcers in the other 2 patients. In the DFU Scale Short-Form, the score decreased in 1 patient and remained unchanged in 3 at 48 weeks. Blood perfusion increased in 1 patient but remained unchanged in 3. In immunohistochemical analysis, the angiogenic, anti-inflammatory, proliferative, and tissue repair biomarkers were elevated in 1 patient and decreased in 3.
CONCLUSIONS: The effects of ESWT appear to maintain certain levels for an extended period of time at 1 year but start to show deterioration on tissue viability. Therefore, it is speculated that intermittent booster ESWT may maintain the effects of ESWT and sustain the tissue viability and repairing. The use of ESWT appeared to be effective for DFU treatment, and extended ESWT showed a tendency of sustaining ESWT effects when multiple booster treatments are utilized in patients with a DFU.

Entities:  

Year:  2019        PMID: 30990778

Source DB:  PubMed          Journal:  Wounds        ISSN: 1044-7946            Impact factor:   1.546


  2 in total

1.  The Efficacy of Li-ESWT Combined With VED in Diabetic ED Patients Unresponsive to PDE5is: A Single-Center, Randomized Clinical Trial.

Authors:  Rongzhen Tao; Jianhuai Chen; Dujian Wang; Yunpeng Li; Jun Xiang; Lei Xiong; Junbiao Ji; Jie Wu; Shuang Zhou; Chunping Jia; Jianlin Lv; Jie Yang; Qinglai Tang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-23       Impact factor: 6.055

2.  Improved Healing of Diabetic Foot Ulcer upon Oxygenation Therapeutics through Oxygen-Loading Nanoperfluorocarbon Triggered by Radial Extracorporeal Shock Wave.

Authors:  Shunhao Wang; Chunyang Yin; Xiaoguang Han; Anyi Guo; Xiaodong Chen; Sijin Liu; Yajun Liu
Journal:  Oxid Med Cell Longev       Date:  2019-08-14       Impact factor: 6.543

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.